Institut de Cancerologie de l'Ouest (ICO) - Saint-Herblain
Institut de Cancerologie de l'Ouest (ICO) - Saint-Herblain
Saint-Herblain, France1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment | Digestive System Diseases, Hepatic Insufficiency, Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, liver disorder, liver failure, neoplasm | Recruiting | Phase 1 | 2026-06-02 | NCT04617522 |